Saturday, October 3, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
News articleYahoo Finance· December 9, 2025

Stock market today: Dow and S&P 500 slip, Nasdaq rises as Fed meeting kicks off, JOLTS data shows openings rose

View original at finance.yahoo.com
Stock market today: Dow and S&P 500 slip, Nasdaq rises as Fed meeting kicks off, JOLTS data shows openings rose US stocks were mixed on Tuesday as the Federal Reserve's December policy meeting kicked off and federal data showed job openings unexpectedly ticked higher even as layoffs jumped…
Opening lines of the source · Yahoo Finance · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Trump would be looking for a new Fed chair to immediately move to cut rates

    80% confidence
  • Exxon expects to hit new earnings and cash flow targets with no increase in capital while generating 17% return on capital employed

    80% confidence
  • Exxon is ahead of its 2030 emissions reduction plans

    80% confidence
  • OPEC can't really afford a $40 or $30 barrel outcome because capital for many member countries is not as loose as in the 2010s

    80% confidence
  • It would be irresponsible to set out Fed rate cut plans for the next six months

    80% confidence
  • Consumers remain intentional in their shopping behaviors with at-home-cooking trends continuing to benefit our brands within our Meals & Beverages portfolio that deliver quality, convenience and value

    80% confidence
  • We believe affordability concerns are pushing the housing market towards equilibrium as home prices are trending towards flat

    80% confidence
  • 55% of US homes are now 40+ years old and will require higher levels of maintenance, repair and renovations in the near future

    80% confidence
  • Several years ago when we began to transform this company, we did so with one objective: to fully unlock our competitive advantages. Today, our transformation is driving industry-leading results

    80% confidence
  • While our Snacks business continues to weather category softness, our brands remain highly relevant

    80% confidence
  • Tesla unsupervised FSD milestone is very close

    80% confidence
  • Affordability concerns and general uncertainty have led consumers to stay put in their homes

    80% confidence
  • We're observing several dynamics that are pressuring housing and unproven demand. First, the elevated interest rate and mortgage rate environment since 2020 has stifled housing turnover as a result of the mortgage lobby effect

    80% confidence
  • Trump's farm bailout would not be possible without tariffs

    80% confidence
  • Housing market experiencing soft demand and choppy conditions this year, though luxury business remains differentiated

    80% confidence
  • Americans' affordability concerns are a con job

    80% confidence
  • Pent-up demand from consumers putting off larger projects can be greater than $20 billion and at some point will be a significant tail

    80% confidence
  • Costs at JPMorgan would rise in 2026 amid competition in credit card space and as AI investments drive higher spending

    80% confidence
  • Housing turnover has remained at historical lows since 2023, which has significantly reduced demand for projects associated with buying and selling money

    80% confidence

Cited in these Via News reports

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Pharma Pipeline Catalysts and M&A Heat Up as AI-Designed Drugs Enter the Clinic
Late-September 2026 brought a dense run of clinical readouts: Novo Nordisk's CagriSema data at EASD, Lilly's ADtouch results for EBGLYSS, and Merck's tulisokibart Phase 2b result. Lilly's $2.9B Merida Biosciences acquisition and the 2026-11-14 FDA PDUFA date for ivonescimab sit alongside these as the main deal and regulatory events. AI-designed drugs such as rentosertib, and speculative AI-linked trial ventures such as QAIAx, are moving from hype toward clinical validation. Broader AI-sector regulatory and legal friction (Tesla Cybercab probe, xAI Minnesota ruling, OpenAI lawsuits) shows rising scrutiny that could spill into AI-driven healthcare.
Our read on the data ›
Signals we're tracking
Satellite-Terrestrial Network Integration Acceleration
Increased investment and launches in hybrid satellite-cellular networks across telecom industry; competitive responses from other carriers; regulatory activity around satellite spectrum; expansion of emergency/rural connectivity use cases
Patterns we're watching ›
Where sources disagree
Apple Inc.
The observation date (2025-12-27) precedes Q1 2026, making it logically impossible to have actual Q1 2026 cash data at that point. Q1 2026 would not end until March 31, 2026. Additionally, the magnitude of the difference ($45.3B vs $132.42) is implausibly large even as a normal quarterly change for Apple. While different fiscal periods can show different values, the timing relationship here suggests a data integrity issue rather than legitimate period-over-period variation.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,985
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,985 facts checked against source5,329 source documents archived
Query this data → isubstrate.com